Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Mechanism of Pharmacological Action”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04736472
What this trial is testing

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

Who this might be right for
Gastrointestinal Cancer
Abramson Cancer Center at Penn Medicine 552
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Testing effectiveness (Phase 2)Study completedNCT01507103
What this trial is testing

Tecemotide (L-BLP25) in Rectal Cancer

Who this might be right for
Rectal Cancer
Merck KGaA, Darmstadt, Germany 124
Early research (Phase 1)Study completedNCT06108479
What this trial is testing

Study of DF6215 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultSolid Tumor Cancer
Dragonfly Therapeutics 35
Not applicableStudy completedNCT03572790
What this trial is testing

Effects of Seven Day Prucalopride Administration in Healthy Volunteers

Who this might be right for
Molecular Mechanisms of Pharmacological ActionDepressionDepressive Disorder+4 more
University of Oxford 50
Post-approval studies (Phase 4)Study completedNCT01743560
What this trial is testing

An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis

Who this might be right for
Oestrogen Receptor Positive Advanced Breast Cancer
Novartis Pharmaceuticals 52
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Very early researchActive Not RecruitingNCT05953038
What this trial is testing

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain

Who this might be right for
Basic Science
Rigshospitalet, Denmark 40
Testing effectiveness (Phase 2)UnknownNCT04933799
What this trial is testing

IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.

Who this might be right for
COVID-19 Pneumonia
Giovanni Franchin, M.D, Ph.D 68
Large-scale testing (Phase 3)Study completedNCT03667690
What this trial is testing

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

Who this might be right for
CandidemiaMycosesFungal Infection+1 more
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 199
Not applicableLooking for participantsNCT06462196
What this trial is testing

Natural History of Depression, Bipolar Disorder and Suicide Risk

Who this might be right for
Behavioral SymptomsSuicideSelf-Injurious Behavior+18 more
National Institute of Mental Health (NIMH) 500
Testing effectiveness (Phase 2)WithdrawnNCT00869869
What this trial is testing

Melatonin Supplementation to Improve Sleep in Patients With Heart Failure

Who this might be right for
Heart FailureSleep Disorders
Brigham and Women's Hospital
Post-approval studies (Phase 4)Study completedNCT05657860
What this trial is testing

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome

Who this might be right for
Prader-Willi SyndromeAggressionSelf-Injurious Behavior+18 more
Maimonides Medical Center 15
Early research (Phase 1)Study completedNCT01162486
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

Who this might be right for
TuberculosisTuberculosis, Pulmonary
Johns Hopkins University 37
Testing effectiveness (Phase 2)Study completedNCT01190735
What this trial is testing

Caffeine for Motor Manifestations of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Ron Postuma 28
Large-scale testing (Phase 3)Study completedNCT02043132
What this trial is testing

Tranexamic Acid in Reverse Total Shoulder Arthroplasty

Who this might be right for
Shoulder Joint DiseaseComplications; ArthroplastyIntraoperative Complications+1 more
Corewell Health East 116
Testing effectiveness (Phase 2)UnknownNCT05375240
What this trial is testing

Propranolol on Post Stroke Immune Status and Infection

Who this might be right for
StrokeCerebrovascular DisordersIschemic Stroke+9 more
Tianjin Medical University General Hospital 45
Post-approval studies (Phase 4)Study completedNCT01201811
What this trial is testing

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Celgene 44
Testing effectiveness (Phase 2)Study completedNCT01397305
What this trial is testing

An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Isofol Medical AB 24
Testing effectiveness (Phase 2)Ended earlyNCT02227368
What this trial is testing

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Who this might be right for
Peripheral Artery Disease (PAD)
AstraZeneca 40
Next Page